Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

From Hit to IND: Streamlining Drug Discovery Through Multidisciplinary Integration

ET
60 Minutes

Drug discovery is a time-consuming and costly endeavor. How can new drug innovators implement more simplified, faster, and streamlined processes to accelerate their programs —especially when working with multiple vendors?  

This webinar will explore the complexity of integrating multidisciplinary functions, including chemistry, biology, pharmacology, project and data management, advanced technologies (AI and Machine Learning), and regulatory compliance. Learn more about Integrated Drug Discovery (IDD), an emerging paradigm that offers many advantages, but also presents unique challenges.  

We’ll explore: 

  • How to manage multidisciplinary integration at the stage of discovery 

  • Key factors, challenges, and solutions for accelerating molecules to clinical stage 

  • Real-world case studies highlighting successful approaches for navigating the drug discovery journey — from hit/lead identification to PCC/IND-enabling milestones 

  • Tips for critical decision-making, such as whether to rely on a single partner for end-to-end support, or engage specialized vendors for different workstreams  

  • And more 

Speakers

BioDuro-HS-Subas.png

Subas Sakya, Ph.D.

Chief Scientific Officer
BioDuro

Dr. Subas Sakya serves as Chief Scientific Officer with nearly 30 years of experience in R&D, driving projects from lead identification to clinic. Throughout his career, Subas has published over 80 articles, patent applications and book chapters with an emphasis on medicinal and organic chemistry. Prior to BioDuro, Subas worked in medicinal chemistry at Pfizer and Wyeth, where he led research across multiple therapeutic areas. While at Pfizer, he also established partnerships with several leading CROs in Europe and gained a comprehensive understanding of CRO industry operations. Subas holds a PhD in organic chemistry from Purdue University.

BioDuro-HS-Babu.png

Babu Boga, Ph.D.

VP of Medicinal Chemistry, Integrated Drug Discovery
BioDuro

Dr. Babu Boga is an experienced leader in pharma, biotech, and CRO, specializing in medicinal chemistry, process research, and strategic outsourcing. He joins BioDuro with a proven track record cultivating global CRO collaborations across the US, China, and India. Babu holds a PhD in carbohydrate chemistry from the Indian Institute of Technology, he completed postdoctoral work in total synthesis and heterocycles at the Scripps Research Institute, San Diego, US, as well as the Université Catholique de Louvain, Belgium, and the Institut Européen de Chimie et Biologie, France. Babu has authored over 64 research publications and patents.

Register here!

Already registered? Click here to login.
Date/Time:
ET